Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cardiac Rehabilitation Devices Market Share

ID: MRFR//1537-CR | 116 Pages | Author: Kinjoll Dey| April 2019

The escalating prevalence of cardiac diseases, exacerbated by the widespread adoption of unhealthy lifestyles marked by elevated cholesterol levels, underscores a growing health crisis worldwide. This trend, driven by factors such as obesity and related health issues, necessitates urgent attention and proactive measures to prevent the progression of cardiac diseases. In response to this pressing need, the National Stroke Association has advocated for crucial lifestyle changes, with a primary focus on smoking cessation and the reduction of "bad" cholesterol levels.

The multifaceted impact of unhealthy lifestyle choices on cardiovascular health is evident in the surge of obesity rates and associated health issues. High cholesterol levels, a common consequence of poor dietary habits and sedentary lifestyles, contribute significantly to the escalating prevalence of cardiac diseases. Recognizing the gravity of the situation, the National Stroke Association recommends a strategic approach to mitigate risk factors, emphasizing lifestyle modifications as a cornerstone of preventive measures.

Smoking, a well-established risk factor for cardiovascular diseases, remains a pervasive concern. The 2014 Surgeon General's Report on smoking and health starkly highlights that cardiovascular disease (CVD) stands as the single largest cause of death in the United States, claiming the lives of more than 800,000 people annually. With over 16 million Americans diagnosed with heart disease, the imperative for impactful interventions to curb this health crisis becomes undeniable. The call for quitting smoking and tobacco products is not merely a preventive measure; it is a proactive step toward reducing the staggering burden of cardiovascular morbidity and mortality in the United States.

The prevalence of cardiac diseases is not confined to the United States alone; it is a global challenge with far-reaching implications. The Americas, characterized by a high acuity information system, substantial disposable income levels, and the rampant adoption of unhealthy lifestyles, emerge as a potential high-growth market for interventions targeting cardiac health. In this region, the confluence of lifestyle factors and a robust healthcare infrastructure positions it as a crucial battleground in the global fight against cardiovascular diseases.

However, the impact of cardiac diseases extends beyond the Americas, with the Asia-Pacific region emerging as another focal point for addressing this health crisis. The region's economic growth and increasing westernization have led to a rising adoption of non-nutritious fast food and sedentary lifestyles, contributing to the surge in cardiac diseases. As societies in the Asia-Pacific region transition toward more westernized dietary patterns, there is a parallel increase in the incidence of cardiovascular risk factors, necessitating comprehensive strategies for prevention and intervention.

To effectively address the growing prevalence of cardiac diseases in the Asia-Pacific region, a holistic approach is imperative. This involves not only targeting individual risk factors but also addressing the broader societal shift towards unhealthy dietary choices and sedentary behaviors. Public health initiatives, educational campaigns, and policy interventions are essential components of a multifaceted strategy to promote heart-healthy lifestyles and mitigate the impact of cardiovascular diseases in the Asia-Pacific region.

In conclusion, the global surge in cardiac diseases, fueled by unhealthy lifestyle choices, demands concerted efforts on multiple fronts. The National Stroke Association's emphasis on lifestyle changes, particularly the cessation of smoking and reduction of "bad" cholesterol levels, reflects a recognition of the pivotal role of preventive measures in combating this health crisis. The Americas, with their high acuity information system and prevalent unhealthy lifestyles, represent a potential high-growth market for interventions. Simultaneously, the Asia-Pacific region, undergoing rapid westernization, presents both challenges and opportunities for addressing the escalating prevalence of cardiac diseases. As the world grapples with the far-reaching impact of cardiovascular health issues, a comprehensive and collaborative approach is essential to effect meaningful change and promote heart-healthy living on a global scale.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation 2022
Historical Data 2018- 2022
Forecast Period 2023-2032
Growth Rate 5.7% (2023-2032)

Global Cardiac Rehabilitation Devices Market Overview


Cardiac Rehabilitation Devices Market Size was valued at USD 1.3 Billion in 2022. The Cardiac Rehabilitation Devices market Phase is projected to grow from USD 1.4 Billion in 2023 to USD 2.02 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.7% during the forecast period (2023 - 2032). The development of medical technology, intense training, unhealthy lifestyles adopted by people of all ages, and the current rise in heart-related problems, are the key market drivers enhancing the market growth.Cardiac Rehabilitation Devices Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Cardiac Rehabilitation Devices Market Trends



  • Dynamic technological innovations and advancements is driving the market growth


Dynamic technological discoveries and advancements are to blame for this increase. The term "tele-cardiac rehabilitation" refers to rehabilitation therapies delivered remotely via telecommunications and information technology. Potentially reducing time, distance, and financial constraints is tele-cardiac rehabilitation. E-cardiology and e-health have advanced significantly in recent years and are anticipated to have an impact on the management and prevention of cardiovascular disease in the near future. Government support is regarded as one of the market drivers with a high impact rendering. For instance, the Centres for Disease Control and Prevention and the Centres for Medicare and Medicaid Services jointly lead the Million Hearts national campaign. By 2017, this effort hopes to stop over a million heart attacks and strokes. In order to improve American residents' health and help them live longer, healthier lives, this project brings together new and existing programmes. ly, the prevalence of lifestyle-related illnesses like obesity, diabetes, and cardiovascular disease is on the rise, which has a significant impact on the expansion of cardiac rehabilitation. Cardiovascular disease is identified as the primary cause of death in the Heart Disease and Stroke Statistics, 2017, a study by the American Heart Association, which accounts for close to 801,000 deaths in the U.S.


CR is a medical advancement that helps to lower weight and improve cardiovascular health. Combining these medical techniques with platforms like artificial intelligence, machine learning, and especially the internet of things (IoT) transforms the field and helps patients with cardiovascular illnesses. The market for cardiac rehabilitation devices provides the healthcare sector with a number of alternatives, including supporting patients in treating their heart conditions and lowering cholesterol, obesity, stress levels, and blood pressure. This is made possible by lower stress levels and better physiological wellness. These factors make treating cardiovascular disorders more effective, which boosts demand for cardiac rehabilitation equipment in new situations. For instance, InBody, a pioneer in body composition technology, unveiled the BP 170 blood pressure monitor in February 2022. This device enables users to track and self-record significant metrics at home.


The  market for cardiac rehabilitation is expanding as a result of an increase in the prevalence of cardiovascular diseases and a rise in the demand for minimally invasive procedures. Furthermore, as a result of the rise in diabetes and obesity prevalence—both of which are known to induce cardiac illnesses—a considerable number of significant businesses have created new preventive technology. Cardiovascular illness was more common in COVID-19 patients, with myocardial injury being the most common diagnosis. As a result, individuals with COVD-19 were more likely to have a wide range of cardiovascular problems, which increased the need for the use of cardiac rehabilitation equipment. Thus, driving the Cardiac Rehabilitation Devices market revenue.


Cardiac Rehabilitation Devices Market Segment Insights


Cardiac Rehabilitation Devices Device Type Insights


The  Cardiac Rehabilitation Devices market segmentation, based on Device Type, includes Elliptical Trainer, Rower, Blood Pressure Monitor, Treadmill, Stabilization Ball, and Heart Rate Monitor. Treadmill segment dominated the  market in 2022. According to the projection for the market for cardiac rehabilitation devices, this trend is expected to continue during the projected period. The prevalence of cardiovascular illnesses and the increased demand for this equipment when conducting cardiac rehabilitation programmes in various contexts are the main causes of the dominance.


Cardiac Rehabilitation Devices End User Insights


The  Cardiac Rehabilitation Devices market segmentation, based on End User, includes Rehab Centers, Research Centers, Specialty Centers, Hospitals, and Clinics. Rehab centers segment dominated the  Cardiac Rehabilitation Devices market in 2022. This is a result of rising health consciousness among the populace and a rise in the quantity of rehabilitation facilities providing rehabilitation therapy in both developed and developing nations. Throughout the predicted period, it is anticipated that this tendency would persist.


Cardiac Rehabilitation Devices Patient Type Insights


The  Cardiac Rehabilitation Devices market segmentation, based on Patient Type, includes Percutaneous Coronary Intervention, Myocardial Ischemia, Coronary Artery Bypass Grafting, and Coronary Artery Disease. Coronary artery disease segment dominated the  Cardiac Rehabilitation Devices market in 2022. Throughout the predicted period, it is anticipated that this tendency would persist. However, because obstructive coronary artery disease is becoming more common among the general population, percutaneous coronary.


Cardiac Rehabilitation Devices Phase Insights


The  Cardiac Rehabilitation Devices market segmentation, based on Phase, includes Phase I, Phase II, and Phase III. Phase III segment dominated the  market in 2022. This is due to the fact that they include digital metres for the convenience and improved experience of heart patients.


Figure 1  Cardiac Rehabilitation Devices Market, by Phase, 2022 & 2032 (USD Billion)


Cardiac Rehabilitation Devices Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Cardiac Rehabilitation Devices Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific Cardiac Rehabilitation Devices market dominated this market in 2022 (45.80%). This is a result of the region's expanding infrastructure, use of cutting-edge technology, rise in the number of people who place a high priority on exercise and health, and growing senior population. It is predicted that the adoption of technological innovation and expanded infrastructure will cause this increase. The need for cardiac rehabilitation equipment is increasing as the population ages and people's awareness of fitness and health grows. Moreover, China’s Cardiac Rehabilitation Devices market held the largest market share, and the Indian Cardiac Rehabilitation Devices market was the fastest growing market in the Asia-Pacific region.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2  CARDIAC REHABILITATION DEVICES MARKET SHARE BY REGION 2022 (USD Billion)


Cardiac Rehabilitation Devices Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


The North America Cardiac Rehabilitation Devices Market is expected to register significant growth from 2023 to 2032. This is because cardiovascular disorders like hypertension, strokes, and coronary heart disease are becoming more prevalent in the area. The United States bears a disproportionately large share of the burden of cardiovascular disease in North America because of its sizable population and evolving lifestyle. The top cause of death in the US, according to estimates, is heart disease. Further, the U.S. Cardiac Rehabilitation Devices market held the largest market share, and the Canada Cardiac Rehabilitation Devices market was the fastest growing market in the North America region.


Europe Cardiac Rehabilitation Devices market accounted for the healthy market share in 2022. The surge in product introductions is to blame for this. Additionally, a rise in the number of regulatory approvals in Europe's industrialised nations had a favourable impact on market expansion. Further, the German Cardiac Rehabilitation Devices market held the largest market share, and the U.K Cardiac Rehabilitation Devices market was the fastest growing market in the European region


Cardiac Rehabilitation Devices Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Cardiac Rehabilitation Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Cardiac Rehabilitation Devices Industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Cardiac Rehabilitation Devices Industry to benefit clients and increase the market sector. In recent years, the Cardiac Rehabilitation Devices Industry has offered some of the most significant advantages to medicine. Major players in the Cardiac Rehabilitation Devices market, including Brunswick Corporation, Core Health & Fitness LLC, Amer Sports, OMRON Corporation, Honey well International Inc., The ScottCare Corporation, BioTelemetry Inc., Schiller, LSI, Ergoline GmbH, Scifit, Ball Dynamics International LLC, Core Health & Fitness LLC, Philips, Smiths Group, Halma plc., LifeWatch AG, and Patterson Companies Inc., are attempting to increase market demand by investing in research and development operations.


A company that offers molecular diagnostic testing services is Royal Philips Electronics. The business offers a platform for molecular diagnostic testing to examine illness samples. A milestone for the efforts to meet the needs to combat SCA (Sudden Cardiac Arrest) was reached in September 2019 when Royal Philips announced the shipment of its two million AEDs.


Halma is made up of 44 active firms that are all distributedly managed. The company strives to create a safer, cleaner, and healthier world through its goods. The organization's three business divisions are safety, environmental and analytical sciences, and healthcare. Smoke detectors, medical supplies, door sensors, and water purification are among Halma's offerings. The majority of the group's products are specialised and face little rivalry. The United States, Europe, and the United Kingdom account for more than 75% of sales. The London Stock Exchange lists Halma. FluxData, which develops and produces cutting-edge digital and multispectral imaging systems for a variety of industries, including the industrial and medical sectors, was purchased by Halma plc in January 2017.


Key Companies in the Cardiac Rehabilitation Devices market include



  • Brunswick Corporation

  • Core Health & Fitness LLC

  • Amer Sports

  • OMRON Corporation

  • Honey Well International Inc.

  • The ScottCare Corporation

  • BioTelemetry Inc.

  • Schiller

  • LSI

  • Ergoline GmbH

  • Scifit

  • Ball Dynamics International LLC

  • Core Health & Fitness LLC

  • Philips

  • Smiths Group

  • Halma plc.

  • LifeWatch AG

  • Patterson Companies Inc.


Cardiac Rehabilitation Devices Industry Developments


June 2022 With the G866 Front-Drive Elliptical, SportsArt introduced the ECO-POWR series. ECO-POWR. Equipment for cardio, strength training, and rehabilitation uses ECO-POWR for the residential, medical, and fitness industries.


Cardiac Rehabilitation Devices Market Segmentation


Cardiac Rehabilitation Devices Device Type Outlook



Cardiac Rehabilitation Devices End User Outlook



  • Rehab Centers

  • Research Centers

  • Specialty Centers

  • Hospitals

  • Clinics


Cardiac Rehabilitation Devices Patient Type Outlook



  • Percutaneous Coronary Intervention

  • Myocardial Ischemia

  • Coronary Artery Bypass Grafting

  • Coronary Artery Disease


Cardiac Rehabilitation Devices Phase Outlook



  • Phase I

  • Phase II

  • Phase III


Cardiac Rehabilitation Devices Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.